GO:0032526 response to retinoic acid: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032526 response to retinoic acid describes any cellular or organismal process that changes state or activity in response to a retinoic acid stimulus.
• Retinoic acid acts primarily through nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which are ligand-activated transcription factors.
• The response controls diverse programs including meiosis commitment, monocyte differentiation, immune regulation, and neural protection.
• Differential responsiveness to retinoic acid among spermatogonia determines precocious differentiation but not meiotic entry during steady-state spermatogenesis.
• Retinoic acid breakdown is required for proximodistal positional identity during axolotl limb regeneration, showing the response is tightly regulated by local metabolism.
• Experimental models such as teratocarcinoma cell lines and hepatocellular carcinoma cells reveal context-dependent retinoic acid responses.
Description
GO:0032526 response to retinoic acid is a biological process defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. Retinoic acid, also known as vitamin A acid, is a metabolite of vitamin A that serves as a potent signaling molecule in development, differentiation, and homeostasis. Researchers study this term because it captures a central mechanism by which cells interpret an external lipid signal and convert it into transcriptional and phenotypic changes. The response is essential for commitment to meiosis, monocyte differentiation, immune response, and neuroprotection. In spermatogenesis, differential responsiveness of spermatogonia to retinoic acid dictates precocious differentiation but not meiotic entry, illustrating the precision of this process. In regenerative contexts, retinoic acid breakdown is required for proximodistal positional identity during axolotl limb regeneration, demonstrating that the response must be spatially and temporally controlled. Cancer research has also linked retinoic acid response to therapeutic outcomes, for example in hepatocellular carcinoma where GSK-126 enhances all-trans-retinoic acid response by upregulating RARG expression. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0032526 for experimental design and generative-AI retrieval.
response to retinoic acid At A Glance
| GO ID | GO:0032526 |
|---|---|
| GO term | response to retinoic acid |
| Ontology | biological_process |
| Synonym | response to vitamin A acid |
| Definition | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. |
| Major function | Mediates cellular and organismal responses to retinoic acid, including transcriptional regulation, differentiation, meiosis commitment, and immune modulation. |
| Key receptors | Retinoic acid receptors (RARs) and retinoid X receptors (RXRs) act as ligand-activated transcription factors. |
| Representative processes | Meiosis commitment, monocyte differentiation, immune response, neuroprotection, limb regeneration. |
| Research relevance | Provides a framework to study differentiation, development, cancer therapy response, and regenerative biology. |
What Is GO:0032526?
In our own words, GO:0032526 response to retinoic acid refers to the collection of cellular and organismal changes triggered when a cell or organism encounters retinoic acid. These changes can include altered gene expression, enzyme production, secretion, movement, or other activities that collectively constitute a response to the retinoic acid stimulus. The term is not limited to a single pathway; it encompasses any downstream process that is initiated or modified by retinoic acid, including transcriptional regulation through retinoic acid receptors and broader physiological outcomes such as differentiation or meiosis commitment.
Why Is response to retinoic acid Important in Cell Biology?
Understanding GO:0032526 response to retinoic acid is important because retinoic acid is a fundamental morphogen and differentiation signal whose dysregulation contributes to developmental defects, infertility, immune dysfunction, and cancer. The process is experimentally tractable and clinically relevant, as shown by studies on spermatogonial differentiation, hepatocellular carcinoma therapy, and neuroprotection. Moreover, the response is context-dependent, as different cell lines can show distinct responses to retinoic acid, making it a rich area for mechanistic and translational research.
• Controls commitment to meiosis, a critical step in germ cell development.
• Regulates monocyte differentiation and immune response, linking retinoic acid to innate immunity.
• Modulates spermatogonial differentiation, with differential responsiveness determining precocious differentiation.
• Influences cancer therapy response, as seen in hepatocellular carcinoma where RARG upregulation enhances ATRA response.
• Exerts antiepileptogenic effects, suggesting roles in neurological disorders.
• Is required for proximodistal positional identity during axolotl limb regeneration, highlighting regenerative roles.
• Shows cell-line-specific responses, as demonstrated in teratocarcinoma cell lines.
• Provides a model for studying nuclear receptor structure and function.
• Offers therapeutic targets for differentiation therapy in oncology.
• Serves as a paradigm for understanding how lipid signals are converted into gene expression programs.
What Happens During response to retinoic acid?
Retinoic acid sensing and receptor activation
In simple terms: Retinoic acid binds to receptor proteins inside the cell, switching them on.
The response begins when retinoic acid enters the cell and binds to retinoic acid receptors (RARs) and retinoid X receptors (RXRs). These receptors are ligand-activated transcription factors, and their structural transitions upon ligand binding are essential for downstream signaling. The journey from single domains to full-length receptor complexes reveals how retinoic acid induces conformational changes that enable DNA binding and cofactor recruitment.
Transcriptional reprogramming
In simple terms: Activated receptors turn genes on or off, changing the cell's behavior.
Once activated, RAR/RXR complexes bind to retinoic acid response elements in DNA and regulate target gene expression. This transcriptional reprogramming underlies many outcomes of the response, including commitment to meiosis and monocyte differentiation. The specific gene sets activated depend on cellular context, as shown by differential responses in spermatogonia and teratocarcinoma cell lines.
Commitment to meiosis
In simple terms: Retinoic acid pushes germ cells toward a special division that makes sperm or eggs.
A well-characterized outcome of retinoic acid response is the commitment to meiosis. Studies in spermatogenesis show that retinoic acid signaling is required for meiotic entry, although differential responsiveness among spermatogonia can dictate precocious differentiation without necessarily triggering meiotic entry during steady-state spermatogenesis. This highlights that the response is not monolithic but depends on cell state and timing.
Immune and differentiation responses
In simple terms: Retinoic acid helps immune cells mature and fight pathogens.
Retinoic acid mediates monocyte differentiation and immune response, linking the response to innate immunity. This includes changes in gene expression that promote differentiation and functional activation of monocytes. Such immune-modulatory roles expand the importance of GO:0032526 beyond development into host defense and inflammation.
Spatial and metabolic control
In simple terms: Cells can break down retinoic acid to control where and when the signal acts.
The response is tightly regulated by local retinoic acid metabolism. In axolotl limb regeneration, retinoic acid breakdown is required for proximodistal positional identity, meaning that degrading the signal is as important as producing it. This spatial control ensures that retinoic acid responses occur in the correct locations and times during regeneration and development.
Key Genes Involved in GO:0032526 response to retinoic acid
The following genes and proteins are central to the response to retinoic acid, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RARA | Retinoic acid receptor alpha; ligand-activated transcription factor mediating retinoic acid signaling | Structural and functional studies of nuclear receptor activation |
| RARB | Retinoic acid receptor beta; mediates transcriptional responses to retinoic acid | Context-dependent target gene regulation |
| RARG | Retinoic acid receptor gamma; upregulation enhances ATRA response in hepatocellular carcinoma | Therapeutic target in HCC and differentiation therapy |
| RXRA | Retinoid X receptor alpha; heterodimerization partner for RARs | Core component of retinoic acid receptor complexes |
| RXRB | Retinoid X receptor beta; participates in RAR/RXR heterodimers | Modulates transcriptional activity of retinoic acid receptors |
| RXRG | Retinoid X receptor gamma; contributes to receptor complex diversity | Tissue-specific retinoic acid responses |
| STRA8 | Stimulated by retinoic acid gene 8; involved in meiosis commitment | Marker and effector of meiotic entry |
| CYP26B1 | Retinoic acid degrading enzyme; controls local retinoic acid levels | Spatial regulation of retinoic acid during regeneration |
| ALDH1A1 | Retinaldehyde dehydrogenase; contributes to retinoic acid synthesis | Upstream regulation of retinoic acid availability |
| ALDH1A2 | Retinaldehyde dehydrogenase; involved in retinoic acid production | Developmental and germ cell roles |
| ALDH1A3 | Retinaldehyde dehydrogenase; retinoic acid synthesis enzyme | Context-dependent retinoic acid generation |
| CYP26A1 | Retinoic acid hydroxylase; degrades retinoic acid | Negative feedback and spatial control |
| CYP26C1 | Retinoic acid degrading enzyme | Regulates retinoic acid gradients |
| RDH10 | Retinol dehydrogenase; contributes to retinoic acid synthesis | Upstream of retinoic acid production |
| CRABP1 | Cellular retinoic acid binding protein; modulates retinoic acid availability | Intracellular transport and metabolism |
| CRABP2 | Cellular retinoic acid binding protein; delivers retinoic acid to receptors | Facilitates nuclear receptor activation |
| FABP5 | Fatty acid binding protein; can influence retinoic acid signaling | Alternative retinoic acid transport |
| PPARB | Peroxisome proliferator-activated receptor beta; interacts with retinoic acid pathways | Crosstalk with nuclear receptor signaling |
How Is response to retinoic acid Regulated?
The response to retinoic acid is regulated at multiple levels. Locally, retinoic acid levels are controlled by synthesis enzymes such as ALDH1A family members and degradation enzymes such as CYP26 family members, which together shape spatial and temporal gradients. In axolotl limb regeneration, retinoic acid breakdown by CYP26 enzymes is required for proximodistal positional identity, demonstrating that catabolism is a key regulatory node. At the receptor level, the availability of RAR and RXR subtypes and their heterodimerization partners influences which genes are activated. Additionally, cellular context determines responsiveness, as different spermatogonia and teratocarcinoma cell lines exhibit distinct responses to retinoic acid. Upregulation of RARG can enhance the response to all-trans-retinoic acid in hepatocellular carcinoma, indicating that receptor expression levels are a regulatory mechanism.
response to retinoic acid and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RARG | Hepatocellular carcinoma; ATRA response enhancement | HCC cell lines with RARG overexpression or knockout |
| STRA8 | Meiosis commitment and infertility | Spermatogonial cell models with STRA8 knockout |
| CYP26B1 | Limb regeneration and positional identity | Axolotl limb regeneration models with CYP26B1 inhibition |
| RARA | Differentiation therapy in leukemia and other cancers | Teratocarcinoma cell lines with RARA mutations |
| ALDH1A2 | Retinoic acid synthesis defects and developmental disorders | Knockout models for retinoic acid deficiency |
Cancer and differentiation therapy
Retinoic acid response is directly linked to cancer biology. In hepatocellular carcinoma, GSK-126 enhances all-trans-retinoic acid (ATRA) response by upregulating RARG expression, suggesting that modulating the response can improve therapeutic outcomes. The broader role of retinoic acid in monocyte differentiation and immune response also connects the pathway to immune surveillance and potential immunotherapies.
Infertility and germ cell defects
The commitment to meiosis is a retinoic acid-dependent process, and disruptions in this response can lead to germ cell defects and infertility. Differential responsiveness of spermatogonia to retinoic acid dictates precocious differentiation but not meiotic entry during steady-state spermatogenesis, indicating that fine-tuning of the response is critical for normal sperm production.
Neurological disorders
Retinoic acid has antiepileptogenic effects, linking the response to neurological disease. This suggests that retinoic acid signaling may be harnessed to prevent epilepsy or modify disease progression, although the mechanisms require further study.
Regenerative medicine
In axolotl limb regeneration, retinoic acid breakdown is required for proximodistal positional identity, highlighting the importance of the response in regenerative contexts. Understanding how retinoic acid gradients are controlled could inform strategies for enhancing regeneration in humans.
From response to retinoic acid-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene mediate retinoic acid-induced differentiation? | CRISPR knockout in teratocarcinoma or HCC cell lines |
| Does a point mutation in RARG alter ATRA response? | Point mutation knock-in in HCC cells |
| Can overexpression of RARG enhance retinoic acid sensitivity? | Overexpression cell model in hepatocellular carcinoma |
| How does retinoic acid affect meiosis commitment? | Spermatogonial cell models with knockout of STRA8 or RARs |
| What is the role of retinoic acid degradation in regeneration? | Axolotl limb regeneration with CYP26B1 manipulation |
| Does retinoic acid modulate immune differentiation? | Monocyte differentiation models with RAR/RXR knockouts |
How to Study the response to retinoic acid Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript changes | Identify retinoic acid-responsive genes |
| CRISPR knockout screening | Gene essentiality for response | Discover novel regulators of retinoic acid response |
| Luciferase reporter assay | Transcriptional activity of RAR/RXR | Test receptor variants and ligands |
| Proteomics | Protein abundance and modifications | Map downstream effectors |
| Imaging | Subcellular localization and dynamics | Visualize receptor and target protein movement |
| Flow cytometry | Differentiation markers | Assess monocyte or germ cell differentiation |
| qRT-PCR | Specific gene expression | Validate target genes like STRA8 or CYP26B1 |
| Western blot | Protein levels and phosphorylation | Confirm receptor or effector expression |
Transcriptomic profiling
RNA-seq can identify global gene expression changes following retinoic acid treatment, revealing the transcriptional program downstream of receptor activation. This approach is useful for comparing responsive versus non-responsive cell lines, such as different teratocarcinoma lines.
Reporter assays and imaging
Retinoic acid response elements can be used in luciferase reporter assays to measure receptor activity. Imaging of fluorescently tagged RARs or target proteins can reveal spatial dynamics of the response, as seen in studies of receptor structure and regeneration.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes required for retinoic acid-induced phenotypes, such as differentiation or growth inhibition. This unbiased approach complements candidate-based studies of RARs and metabolic enzymes.
Proteomics and interactomics
Mass spectrometry-based proteomics can map changes in protein abundance and post-translational modifications after retinoic acid treatment. Interactomics can identify cofactors recruited to RAR/RXR complexes, building on structural insights.
How CRISPR Can Be Used to Study GO:0032526 response to retinoic acid
Knockout
CRISPR knockout of genes such as RARG, STRA8, or CYP26B1 can test their requirement for retinoic acid-induced phenotypes. For example, knocking out RARG in hepatocellular carcinoma cells would determine whether its upregulation is necessary for enhanced ATRA response. Knockout of STRA8 can assess its role in meiosis commitment.
Point Mutation
Point mutations in receptor genes can mimic clinical variants or disrupt ligand binding. Introducing point mutations in RARA or RARG can reveal how specific residues affect retinoic acid response and receptor structure-function relationships.
Knock-in
Knock-in of tagged versions of RARs or metabolic enzymes allows tracking of protein localization and interactions. This is useful for studying receptor complex dynamics and retinoic acid gradient formation during regeneration.
Overexpression
Overexpression of RARG or other pathway components can sensitize cells to retinoic acid. In hepatocellular carcinoma, RARG overexpression enhances ATRA response, providing a model to study differentiation therapy. Overexpression in teratocarcinoma cells can also reveal context-dependent effects.
How EDITGENE Supports response to retinoic acid Research
Researchers studying response to retinoic acid-related genes often need to determine whether a candidate gene is causally involved in the response or merely correlated with it. EDITGENE provides CRISPR-based cell model services to enable such causal tests across knockout, point mutation, knock-in, and overexpression formats, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for response to retinoic acid research.
Frequently Asked Questions About response to retinoic acid
What is GO:0032526 response to retinoic acid?
GO:0032526 is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a retinoic acid stimulus.
What genes are involved in response to retinoic acid?
Key genes include RARA, RARB, RARG, RXRA, RXRB, RXRG, STRA8, CYP26B1, ALDH1A1, ALDH1A2, and ALDH1A3, among others.
How does retinoic acid signaling work?
Retinoic acid binds to RAR/RXR heterodimers, which then regulate transcription of target genes, leading to changes in differentiation, meiosis, or immune function.
What is the role of retinoic acid in meiosis?
Retinoic acid is required for commitment to meiosis, and differential responsiveness of spermatogonia can dictate precocious differentiation but not meiotic entry during steady-state spermatogenesis.
How is retinoic acid response regulated?
It is regulated by synthesis and degradation enzymes such as ALDH1A and CYP26 families, receptor expression levels, and cellular context.
What diseases are linked to retinoic acid response?
It is linked to cancer (e.g., hepatocellular carcinoma), infertility, neurological disorders such as epilepsy, and regenerative defects.
Can CRISPR be used to study response to retinoic acid?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the causal role of genes in the response.
What cell models are used for retinoic acid research?
Common models include teratocarcinoma cell lines, hepatocellular carcinoma cells, spermatogonial cells, monocytes, and axolotl limb regeneration models.
What is the synonym for GO:0032526?
The synonym is response to vitamin A acid.
Why is retinoic acid response important in cancer?
In hepatocellular carcinoma, upregulation of RARG enhances ATRA response, suggesting that modulating this pathway can improve differentiation therapy.
Conclusion
GO:0032526 response to retinoic acid is a broad biological process that encompasses receptor activation, transcriptional reprogramming, and diverse physiological outcomes such as meiosis commitment, immune differentiation, and regeneration. Its dysregulation is implicated in cancer, infertility, and neurological disorders, making it a compelling target for mechanistic and translational research. By combining QuickGO definitions with verified literature, this article provides a foundation for designing CRISPR-based experiments to dissect the response to retinoic acid.
References
- 1. Gewiss RL et al.. 2021. The role of retinoic acid in the commitment to meiosis.. Asian J Androl 23(6):549-554 PMID: 34472453
- 2. Rastinejad F. 2022. Retinoic acid receptor structures: the journey from single domains to full-length complex.. J Mol Endocrinol 69(4):T25-T36 PMID: 36069789
- 3. Unknown. 2020. Retinoic Acid Mediates Monocyte Differentiation and Immune Response.. Cancer Discov 10(5):OF7 PMID: 32198131
- 4. Johnson TA et al.. 2023. Differential responsiveness of spermatogonia to retinoic acid dictates precocious differentiation but not meiotic entry during steady-state spermatogenesis†.. Biol Reprod 108(5):822-836 PMID: 36708226
- 5. Liu Z et al.. 2024. GSK-126 Enhances All-Trans-Retinoic Acid (ATRA) Response in Hepatocellular Carcinoma (HCC) by Upregulating RARG Expression.. Discov Med 36(184):1041-1053 PMID: 38798263
- 6. Rosiles-Abonce A et al.. 2021. Antiepileptogenic Effect of Retinoic Acid.. Curr Neuropharmacol 19(3):383-391 PMID: 32351181
- 7. Duerr TJ et al.. 2025. Retinoic acid breakdown is required for proximodistal positional identity during axolotl limb regeneration.. Nat Commun 16(1):4798 PMID: 40494878
- 8. Wan YJ et al.. 1995. Different response to retinoic acid of two teratocarcinoma cell lines.. Exp Cell Res 219(2):392-8 PMID: 7543852
